Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2365-421X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow) ; volume:5 ; number:1 ; day:1 ; month:5 ; year:2020 ; pages:1-11 ; date:12.2020
EJNMMI radiopharmacy and chemistry ; 5, Heft 1 (1.5.2020), 1-11, 12.2020
- Creator
-
Aalbersberg, Else A.
Andel, Lotte van
Geluk-Jonker, Martine M.
Beijnen, Jos H.
Stokkel, Marcel P. M.
Hendrikx, Jeroen J. M. A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41181-020-00095-9
- URN
-
urn:nbn:de:101:1-2020071121391358822546
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Aalbersberg, Else A.
- Andel, Lotte van
- Geluk-Jonker, Martine M.
- Beijnen, Jos H.
- Stokkel, Marcel P. M.
- Hendrikx, Jeroen J. M. A.
- SpringerLink (Online service)
Other Objects (12)
![The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer](/assets/placeholder/searchResultMediaUnknown.png)
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
Bestimmung der Ganzkörpertumorlast in der 99mTc-PSMA Bildgebung mittels künstlicher Intelligenz
Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
Potenzial der 99mTc-MIP-1404-PSMA-Szintigrafie zum Primärstaging bei Patienten mit Prostatakarzinom
![Erythrozytenmarkierung mit 99mTc [Tc]](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Erythrozytenmarkierung mit 99mTc [Tc]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Planar 99mTc-PSMA Imaging of Prostate Cancer in a Low-Resource Setting: A Series Report
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
Bestimmung der Ganzkörpertumorlast in der 99mTc-PSMA Bildgebung mittels künstlicher Intelligenz
Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
Potenzial der 99mTc-MIP-1404-PSMA-Szintigrafie zum Primärstaging bei Patienten mit Prostatakarzinom
Erythrozytenmarkierung mit 99mTc [Tc]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Planar 99mTc-PSMA Imaging of Prostate Cancer in a Low-Resource Setting: A Series Report
Tc-99m-PSMA-SPECT/CT Is Superior to Tc-99m-MDP-SPECT/CT in the Staging of Prostatic Cancer with Osseous Metastases after External Beam Radiotherapy
The Theranostic Optimization of PSMA-GCK01 Does Not Compromise the Imaging Characteristics of [99mTc]Tc-PSMA-GCK01 Compared to Dedicated Diagnostic [99mTc]Tc-EDDA/HYNIC-iPSMA in Prostate Cancer
Diagnostic efficacy of [99mTc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis
[18F]PSMA-1007 PET is comparable to [99mTc]Tc-DMSA SPECT for renal cortical imaging
Bestimmung der Ganzkörpertumorlast in der 99mTc-PSMA Bildgebung mittels künstlicher Intelligenz
Comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer: a protocol for systematic review and meta-analysis
Potenzial der 99mTc-MIP-1404-PSMA-Szintigrafie zum Primärstaging bei Patienten mit Prostatakarzinom
Erythrozytenmarkierung mit 99mTc [Tc]
44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
Real world experience with [99mTc]Tc-HYNIC-iPSMA SPECT prostate cancer detection: interim results from the global NOBLE registry
Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
Planar 99mTc-PSMA Imaging of Prostate Cancer in a Low-Resource Setting: A Series Report